ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 146 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $13,674,000 | +60.2% | 725,000 | 0.0% | 0.01% | +40.0% |
| Q2 2019 | $8,533,000 | -13.8% | 725,000 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $9,896,000 | +94.5% | 725,000 | +196.4% | 0.01% | +66.7% |
| Q1 2017 | $5,088,000 | 0.0% | 244,600 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $5,088,000 | -37.9% | 244,600 | -2.2% | 0.00% | -25.0% |
| Q3 2016 | $8,193,000 | +31.2% | 250,000 | 0.0% | 0.00% | +33.3% |
| Q2 2016 | $6,243,000 | -65.9% | 250,000 | -60.3% | 0.00% | -62.5% |
| Q4 2014 | $18,311,000 | +115.5% | 629,472 | -6.1% | 0.01% | +100.0% |
| Q3 2014 | $8,498,000 | -48.4% | 670,200 | -18.3% | 0.00% | -42.9% |
| Q2 2014 | $16,467,000 | – | 820,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
| Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
| PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
| Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
| PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
| Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
| CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
| Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |